Thermo Fisher Scientific (TMO) Declares $0.15 Quarterly Dividend; 0.4% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St set for higher open tech gains offset bond-market jitters
- Oil prices rise as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- Alphabet shares up in premarket trade after Gemini 4 Argon launch
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
Thermo Fisher Scientific (TMO) Collaborates with Seegene on Separate FDA Filings in Conjunction with Allplex and QuantStudio
May 22, 2017 6:05 AM EDTSeegene Inc. today announced that it has entered into a new strategic collaboration relationship with Thermo Fisher Scientific (NYSE: TMO) in which Seegene will file for U.S Food and Drug Administration (FDA) clearance of its Allplex diagnostic assay portfolio at the same time that Thermo Fisher files for FDA clearance to run Seegene's assays on Thermo Fisher's QuantStudio 5 Real-Time PCR System (PCR System).
Seegene's Allplex assay opens a new level of innovation to the market by enabling a comprehensive MDx solution. Coupled with Thermo... More
